Investment legend Charlie Munger, renowned for his wisdom and influence in the world of finance, has passed away at the age of 99.

The news of his death has prompted an outpouring of tributes from business leaders, investors, and admirers around the globe.

Munger, best known as Warren Buffett’s right-hand man and vice chairman of Berkshire Hathaway, leaves behind a legacy of unparalleled success and a treasure trove of investment insights. His timeless wisdom on value investing, rational decision-making, and the importance of lifelong learning has inspired countless individuals in their pursuit of financial excellence.

Notable figures like Warren Buffett, Bill Gates, and Elon Musk have expressed their deep sorrow at Munger’s passing. Buffett, his close friend and business partner, referred to Munger as his “partner in all things important” and praised his unparalleled intellect and integrity.

As the world mourns the loss of this investment sage, many are left wondering about the future of Berkshire Hathaway and the investment world as a whole. Munger’s legacy is sure to endure, but how will his absence impact the strategies and decisions of those who looked up to him for guidance?

“Charlie Munger was a legendary figure in the investment community,” said Brian Moynihan, the CEO of Bank of America, adding that “there are many who benefited greatly from his wisdom”.

Biotech breakthrough has Pancreatic Cancer in its sights with new treatments

Pancreatic Cancer, ranking as the third leading cause of cancer-related deaths in Australia, grapples with a disheartening 11.5% survival rate—one of the lowest among malignancies. Compounding the issue, late-stage diagnosis and a lack of awareness regarding early signs and symptoms contribute to the grim prognosis. The available treatment options for pancreatic cancer are not only limited but also exhibit a worrying lack of efficacy.

However, a ray of hope emerges from groundbreaking biotechnological advancements that have recently surfaced. These innovations offer the potential to eradicate cancer with minimal side effects, marking a significant stride in the quest for more effective treatments.

As the world observes November as World Pancreatic Cancer Awareness Month, the spotlight falls on Johnny Quattro from VentureCrowd. He shares insights into EnGeneIC’s latest success, shedding light on the strides being made in the realm of biotechnology to combat pancreatic cancer. This promising development underscores the importance of raising awareness, fostering early detection, and advancing cutting-edge treatments to improve the outlook for those affected by this formidable disease.

Can industries practice for a greener tomorrow?

Industrial sustainability is evolving, as businesses in this sector actively seek environmentally conscious solutions to reduce their ecological footprint. From adopting renewable energy sources to implementing waste reduction measures, companies are reshaping their practices to align with global sustainability goals.

In the pursuit of industrial sustainability, businesses are integrating green technologies, embracing circular economies, and prioritising ethical supply chain management. These efforts not only benefit the environment but also position companies as responsible corporate citizens, appealing to a growing environmentally conscious consumer base.

Carlos Urbano, Vice President of Industry, Pacific Zone at Schneider Electric, tells us more about green technologies.

Schneider Electric is at the forefront of the digital transformation of energy management and automation.